FTO and acute promyelocytic leukemia: Nevertheless, the FTO-mediated APL progression is not only by targeting mRNA destabilization, but also by affecting the efficacy of ‘ATRA-mediated therapy’ [69,70] justified by analyzing NB4 cell (human acute promyelocytic leukaemia cell line) differentiation marker.